Investigational Site Number 410004

Seoul 120-752

0 studies enrolling now · 10 studies all time

What they study most

Asthma, Atherosclerotic Cardiovascular Disease, Hematopoietic Neoplasm, Idiopathic Pulmonary Fibrosis, Multiple Sclerosis Relapse, Prostate Cancer, Venous Thromboembolism

Studies at this site

• Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia — Completed
• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed
• Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
• An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma — Completed
• Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer — Completed
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early
• Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery — Completed